Novavax (NVAX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.17 +2.64%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $8.03 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Live Ventures (LIVE) Reports Q3 Loss of $0.34
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
